Internal Reference Number: FOI_9280
Date Request Received: 12/03/2026 00:00:00
Date Request Replied To: 23/03/2026 00:00:00
This response was sent via: By Email
Request Summary: Head and Neck cancer
Request Category: Researcher
| Question Number 1: Does your Trust treat patients for head and neck cancer (Squamous cell carcinoma)? If no, which Trust do you refer patients onto for treatment? | |
| Answer To Question 1: SFT do not provide treatment to the Head & Neck patients, they are referred to UHS. | |
| Question Number 2: Within your trust, how many patients have been treated in the past 3 months for head and neck cancer (squamous cell carcinoma) with the following? 鈥� Surgery only 鈥� Radiotherapy only 鈥� Surgery + Radiotherapy 鈥� Carboplatin (only or in combination with 5-FU) 鈥� Cisplatin (only or in combination with 5-FU) 鈥� Cetuximab with/without chemotherapy 鈥� Cetuximab with radiotherapy 鈥� Pembrolizumab monotherapy 鈥� Pembrolizumab with chemotherapy 鈥� Nivolumab 鈥� Docetaxel (only or in combination with 5-FU) 鈥� Fluorouracil (5FU) monotherapy 鈥� Any other chemotherapy (without radiotherapy) 鈥� Any other chemotherapy (with radiotherapy) | |
| Answer To Question 2: N/A | |
| Question Number 3: Could you please provide the number of patients treated in the past 3 months with the following agents for metastatic head and neck cancer (squamous cell carcinoma)? 鈥� Cetuximab with/without chemotherapy 鈥� Pembrolizumab monotherapy 鈥� Pembrolizumab with chemotherapy 鈥� Nivolumab 鈥� Docetaxel (only or in combination with 5-FU) 鈥� Any other chemotherapy (without radiotherapy) 鈥� Any other chemotherapy (with radiotherapy) | |
| Answer To Question 3: N/A | |
| Question Number 4: How many patients who received Pembrolizumab for head and neck cancer (squamous cell carcinoma) in the last 3 months, received: 鈥� Treatment every 3 weeks (200mg, Q3W) 鈥� Treatment every 6 weeks (400mg, Q6W) | |
| Answer To Question 4: N/A | |
| Question Number 5: Does your trust participate in any clinical trials for head and neck cancer? If so, please provide the trial details and number of patients who are taking part. | |
| Answer To Question 5: No, SA国际传媒 is not currently participating in any clinical trials for head and neck cancer. | |
| To return to the list of all the FOI requests please click here |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
